Innocan Pharma

Innocan Pharma is a pharmaceutical technology company divided into two main divisions: Pharmaceuticals and Consumer Health. In the pharmaceutical field, Innocan focuses on developing innovative drug delivery platform technologies based on cannabinoid science to treat various conditions and improve patients' quality of life. This area involves two drug delivery technologies: (i) the LPT CBD-loaded liposome platform, which facilitates precise dosing and the long-term, controlled release of CBD into the bloodstream; preclinical trials for the LPT delivery platform are currently underway for two indications: epilepsy and pain management; (ii) the CLX CBD-loaded exosome platform, which aims to target the central nervous system through regeneration and resolution of inflammation. In the consumer health sector, Innocan develops and markets a range of innovative self-care products to promote healthier lifestyles. In this field, Innocan has established a joint venture named BI Sky Global Ltd., focusing on advanced targeted online sales.